Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor

Laprairie, R B, Bagher, A M, Kelly, M E M, Denovan‐Wright, E M·2015·British Journal of Pharmacology

Cited by (1,000)

Items 401–500 of 1,000

  1. (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice
    Isabel González‐Mariscal, Beatriz Carmona‐Hidalgo, Matthias Winkler, Juan Diego Unciti-Broceta, Alejandro Escamilla, María Gómez‐Cañas, Javier Fernández‐Ruíz, Bernd L. Fiebich, Silvana‐Yanina Romero‐Zerbo, Francisco Javier Bermúdez‐Silva et al. · 2021 · Pharmacological Research
  2. Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks
    Natalie Ertl, Tom P. Freeman, Claire Mokrysz, Shelan Ofori, Anna Borissova, Kat Petrilli, H. Valerie Curran, Will Lawn, Matthew B. Wall · 2024 · Neuropsychopharmacology
  3. In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities
    Fatima-Zahrae Laaboudi, Mohamed Rejdali, Hassan Amhamdi, Amin Salhi, Abdellah Elyoussfi, M’hamed Ahari · 2024 · Toxicology Reports
  4. Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
    João Luís Q. Simei, José Diogo R. Souza, João Francisco Cordeiro Pedrazzi, Francisco Silveira Guimarães, Alline Cristina Campos, Antônio Waldo Zuardi, Jaime E. C. Hallak, José Alexandre S. Crippa · 2024 · Pharmaceuticals
  5. Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study
    Javier Vázquez-Bourgón, Esther Setién‐Suero, Fuencisla Pilar-Cuéllar, Rodrigo Romero-Jiménez, Víctor Ortiz‐García de la Foz, Elena Castro, Benedicto Crespo‐Facorro · 2019 · Journal of Psychopharmacology
  6. hiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation
    Cláudia C. Miranda, Tiago Barata, Sandra Henriques Vaz, Carla Ferreira, Alexandre Quintas, Evguenia Bekman · 2020 · Frontiers in Molecular Neuroscience
  7. CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice
    Miguel Ángel Luján, Laia Alegre-Zurano, Ana Martín‐Sánchez, Lídia Cantacorps, Olga Valverde · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  8. Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report
    Ana Carolina Ruver-Martins, Maira Assunção Bicca, Fabiano Soares de Araujo, Beatriz Helena Lameiro de Noronha Sales Maia, Fabrício A. Pamplona, Élton Gomes da Silva, Francisney Pinto do Nascimento · 2022 · Journal of Medical Case Reports
  9. Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model
    Carlos Henrique Alves Jesus, Matheus Vinícius Ferreira, Aléxia Thamara Gasparin, Evelize Stacoviaki Rosa, Karina Genaro, José Alexandre S. Crippa, Juliana Geremias Chichorro, Joice Maria da Cunha · 2022 · Behavioural Brain Research
  10. Single cannabidiol administration affects anxiety-, obsessive compulsive-, object memory-, and attention-like behaviors in mice in a sex and concentration dependent manner
    Carley Marie Huffstetler, Brigitte Cochran, Camilla Ann May, Nicholas Maykut, Claudia Rose Silver, Claudia Cedeno, Ezabelle Franck, Alexis N. Cox-Holmes, Debra Ann Fadool · 2022 · Pharmacology Biochemistry and Behavior
  11. Structure–Activity Relationship Study of Cannabidiol-Based Analogs as Negative Allosteric Modulators of the μ-Opioid Receptor
    Taryn Bosquez-Berger, Jessica A. Gudorf, Charles P. Kuntz, Jacob A. Desmond, Jonathan P. Schlebach, Michael S. VanNieuwenhze, Alex J. Straiker · 2023 · Journal of Medicinal Chemistry
  12. Cannabidiol Inhibits the Proliferation and Invasiveness of Prostate Cancer Cells
    Eve O’Reilly, Karima Khalifa, Joanne M. Cosgrave, Haleema Azam, Maria Prencipe, Jeremy C. Simpson, William M. Gallagher, Antoinette Sabrina Perry · 2023 · Journal of Natural Products
  13. Effects of central RVD-hemopressin(α) administration on anxiety, feeding behavior and hypothalamic neuromodulators in the rat
    Lucia Recinella, Annalisa Chiavaroli, Claudio Ferrante, Adriano Mollica, Giorgia Macedonio, Azzurra Stefanucci, Marilisa Pia Dimmito, Szabolcs Dvorácskó, Csaba Tömböly, Luigi Brunetti et al. · 2018 · Pharmacological Reports
  14. Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats
    Amanda Nunes Santiago, Marco Mori, Francisco Silveira Guimarães, Humberto Milani, Rúbia Maria Weffort de Oliveira · 2018 · Neurotoxicity Research
  15. Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?
    Courtney Griffiths, James Aikins, David Philip Warshal, Olga Ostrovsky · 2021 · Biomolecules
  16. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a protocol for an overview of systematic reviews and a systematic review of randomised controlled trials
    Emma Fisher, Christopher Eccleston, Louisa J Degenhardt, David P. Finn, Nanna Brix Finnerup, Ian Gilron, Simon Haroutounian, Elliot J. Krane, Andrew S.C. Rice, Michael C. Rowbotham et al. · 2019 · PAIN Reports
  17. The Cannabinoid CB1 Receptor in Schizophrenia
    Faith Borgan, Michelle Kokkinou, Oliver David Howes · 2020 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  18. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol
    Brandon Gunasekera, Cathy Davies, Rocío Martín‐Santos, Sagnik Bhattacharyya · 2020 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  19. Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
    Klaudia Berk, Wiktor Bzdęga, Karolina Konstantynowicz-Nowicka, Tomasz Charytoniuk, Hubert Żywno, Adrian Chabowski · 2021 · Journal of Clinical Medicine
  20. Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis
    Patrycja Bielawiec, Sylwia Dziemitko, Karolina Konstantynowicz-Nowicka, Adrian Chabowski, Janusz Bogdan Dzięcioł, Ewa Harasim‐Symbor · 2023 · Scientific Reports
  21. Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
    Rosaria Greco, Miriam Francavilla, Chiara Demartini, Anna Maria Zanaboni, Mikael Hans Sodergren, Sara Facchetti, Barbara Pacchetti, Michela Palmisani, Valentina Franco, Cristina Tassorelli · 2023 · The Journal of Headache and Pain
  22. Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders
    Kristine Rømer Thomsen, Birgitte Thylstrup, Michael Mulbjerg Pedersen, Mads Uffe Pedersen, Erik Hertel Simonsen, Morten Hesse · 2017 · Schizophrenia Research
  23. Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats
    Eric Murillo‐Rodríguez, Gloria Arankowsky‐Sandoval, Nuno Rocha, Rodrigo Peniche-Amante, André Barciela Veras, Sergio Eduardo de Carvalho Machado, Henning Budde · 2018 · Neurochemical Research
  24. Novel inverse agonists for the orphan G protein-coupled receptor 6
    Alyssa S. Laun, Sarah H. Shrader, Zhao-Hui Song · 2018 · Heliyon
  25. Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol
    Ana Martín‐Sánchez, Héctor González‐Pardo, Laia Alegre-Zurano, Adriana Castro‐Zavala, Isabel López-Taboada, Olga Valverde, Nélida M. Conejo · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  26. Recommendation to reconsider examining cannabis subtypes together due to opposing effects on brain, cognition and behavior.
    Rømer Thomsen, Kristine, Callesen, Mette Buhl, Feldstein Ewing, Sarah W. · 2017 · Neuroscience & Biobehavioral Reviews
  27. Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal.
    Kevin, Richard C., Allsop, David J., Lintzeris, Nicholas, Dunlop, Adrian J., Booth, Jessica, McGregor, Iain S. · 2017 · Forensic Toxicology
  28. Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ 9 ‐Tetrahydrocannabinol Without Improving Its Analgesic Properties
    Andriy A. Gorbenko, Jules A. A. C. Heuberger, Linda E. Klumpers, Marieke L. de Kam, Pamela K. Strugala, Saco J. de Visser, Geert Jan Groeneveld · 2024 · Clinical Pharmacology & Therapeutics
  29. Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice
    Aymen H. Sadaka, Ana G. Ozuna, Richard J. Ortiz, Praveen Kulkarni, Clare T. Johnson, Heather B. Bradshaw, Bruce S. Cushing, Ai-Ling Li, Andrea G. Hohmann, Craig F. Ferris · 2021 · Journal of Translational Medicine
  30. A Mini-Review of Relationships Between Cannabis Use and Neural Foundations of Reward Processing, Inhibitory Control and Working Memory
    Kristen P. Morie, Marc Nicholas Potenza · 2021 · Frontiers in Psychiatry
  31. Biosynthesis of Nature-Inspired Unnatural Cannabinoids
    Kevin Jie Han Lim, Yan Ping Lim, Yossa Dwi Hartono, Maybelle Kho Go, Hao Fan, Wen Shan Yew · 2021 · Molecules
  32. Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice
    Xiao Han, Xiankui Song, Dake Song, Guanbo Xie, Hongyan Guo, Ning Wu, Jin Li · 2022 · Psychopharmacology
  33. Individual and combined effects of cannabidiol and Δ 9 -tetrahydrocannabinol on striato-cortical connectivity in the human brain
    Matthew B. Wall, Tom P. Freeman, Chandni Hindocha, Lysia Demetriou, Natalie Ertl, Abigail M. Freeman, A. Jones, Will Lawn, Rebecca Anne Pope, Claire Mokrysz et al. · 2022 · Journal of Psychopharmacology
  34. Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study
    Gyula Váradi, Zhen Zhu, Henry D. Crowley, Marc Moulin, Rajib Kumar Dey, Erin Diane Lewis, Malkanthi Evans · 2022 · Advances in Therapy
  35. Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
    Robert Ramer, Burkhard Hinz · 2022 · Cells
  36. Cannabidiol Exerts Sedative and Hypnotic Effects in Normal and Insomnia Model Mice Through Activation of 5-HT1A Receptor
    Yumeng Liu, Jin-Cao Li, Yong-Fang Gu, Ren-Hong Qiu, Jiaying Huang, Rui Xue, Shuo Li, Yang Zhang, You‐Zhi Zhang, You‐Zhi Zhang · 2024 · Neurochemical Research
  37. Cannabis and Migraine: It’s Complicated
    Laszlo L. Mechtler, Fran M. Gengo, Vincent Bargnes · 2021 · Current Pain and Headache Reports
  38. Cannabinoid Signaling in Kidney Disease
    Liana Arceri, Thanh Khoa Nguyen, Shannon G. Gibson, Sophia Baker, Rebecca A. Wingert · 2023 · Cells
  39. Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
    Siyuan Shen, Chao Wu, Zhiqian Yang, Kexin Wang, Zhenhua Shao, Wei Yan · 2025 · Acta Pharmacologica Sinica
  40. Biological Activity of Cannabis sativa L. Extracts Critically Depends on Solvent Polarity and Decarboxylation
    Guillermo Moreno‐Sanz, Carlos Ferreiro‐Vera, Carolina Sánchez-Carnerero Callado, Xavier Nadal, Verónica Sánchez de Medina · 2020 · Separations
  41. Antiseizure effects of the cannabinoids in the amygdala‐kindling model
    Merrick S. Fallah, Lukasz Dlugosz, Brian W. Scott, Miles D. Thompson, W. McIntyre Burnham · 2021 · Epilepsia
  42. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum
    João Francisco Cordeiro Pedrazzi, Amanda J. Sales, Francisco Silveira Guimarães, Sâmia R.L. Joca, José A. Crippa, Elaine Aparecida Del Bel · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  43. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain
    Stevie C. Britch, Rebecca M. Craft · 2022 · Journal of Pain
  44. CBD enhances the cognitive score of adolescent rats prenatally exposed to THC and fine-tunes relevant effectors of hippocampal plasticity
    Valentina Castelli, Gianluca Lavanco, Cesare D’Amico, Salvatore Feo, Giuseppe Tringali, Martin Kuchař, Carla Cannizzaro, Anna Brancato · 2023 · Frontiers in Pharmacology
  45. Therapeutic Potential of Cannabinoids in Glaucoma
    Theresa Lindner, Doreen Schmidl, Laura Peschorn, Viktoria Pai, Alina Popa‐Cherecheanu, Jacqueline Chua, Leopold F. Schmetterer, Gerhard Garhöfer · 2023 · Pharmaceuticals
  46. Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review
    Inga Dammann, Cathrin Rohleder, F. Markus Leweke · 2024 · Pharmacopsychiatry
  47. Reducing Effect of Cannabidiol on Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats
    Paola Maccioni, Jessica Bratzu, Mauro A.M. Carai, Giancarlo Colombo, Gian Luigi Gessa · 2021 · Cannabis and Cannabinoid Research
  48. Traumatic brain injury and the misuse of alcohol, opioids, and cannabis
    Alejandra Jacotte-Simancas, Elizabeth A. Fucich, Zachary F. Stielper, Patricia E. Molina · 2020 · International review of neurobiology
  49. The CB2 Receptor as a Novel Therapeutic Target for Epilepsy Treatment
    Xiaoyu Ji, Yang Zeng, Jie Wu · 2021 · International Journal of Molecular Sciences
  50. Cannabidiol – A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance
    Tomasz Charytoniuk, Klaudia Sztolsztener, Ewa Harasim‐Symbor, Klaudia Berk, Adrian Chabowski, Karolina Konstantynowicz-Nowicka · 2021 · Biomedicine & Pharmacotherapy
  51. Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study
    Joji Suzuki, Bianca Martin, Sara Prostko, Peter Ray Chai, Roger D. Weiss · 2022 · Integrative Medicine Reports
  52. Molecular Mechanisms Through Which Cannabidiol May Affect Skeletal Muscle Metabolism, Inflammation, Tissue Regeneration, and Anabolism: A Narrative Review
    Moniek Schouten, Sebastiaan Dalle, Katrien Koppo · 2022 · Cannabis and Cannabinoid Research
  53. Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol
    Jessica L. Beers, Aurora K. Authement, Nina Isoherranen, Klarissa D. Jackson · 2023 · ACS Medicinal Chemistry Letters
  54. The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies
    Samantha M. Ayoub, Breanna M. Holloway, Alannah H. Miranda, Benjamin Z. Roberts, Jared W. Young, Arpi Minassian, Ronald J. Ellis · 2024 · Current HIV/AIDS Reports
  55. Interplay between cannabinoids and the neuroimmune system in migraine
    Erik Zorrilla, Adriana Della Pietra, Andrew F. Russo · 2024 · The Journal of Headache and Pain
  56. Modulation of the Endocannabinoid System Following Central Nervous System Injury
    Juan Zhou, Haneen Noori, Ian Burkovskiy, J. Daniel Lafreniere, Melanie E. M. Kelly, Christine Lehmann · 2019 · International Journal of Molecular Sciences
  57. Selective modulation of the cannabinoid type 1 (CB 1 ) receptor as an emerging platform for the treatment of neuropathic pain
    Samuel D. Banister, Kaavya Krishna Kumar, Vineet Kumar, Brian K. Kobilka, Sanjay V. Malhotra · 2019 · MedChemComm
  58. Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder
    Pamela Sabioni, Bernard Le Foll · 2019 · FOCUS The Journal of Lifelong Learning in Psychiatry
  59. Hair Regrowth with Cannabidiol (CBD)-rich Hemp Extract – A Case Series
    Gregory Lawson Smith, John L. Satino · 2021 · Cannabis
  60. Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway
    Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée · 2021 · Molecular Psychiatry
  61. Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ9-tetrahydrocannabinol
    Richard Kanyo, Md Ruhul Amin, Laszlo F. Locskai, Danika D. Bouvier, Alexandria M. Olthuis, W. Ted Allison, Declan W. Ali · 2021 · Scientific Reports
  62. Impact of the mouse estrus cycle on cannabinoid receptor agonist‐induced molecular and behavioral outcomes
    Hye Ji J. Kim, Ayat Zagzoog, Tallan Black, Sarah L. Baccetto, Udoka C. Ezeaka, Robert B. Laprairie · 2022 · Pharmacology Research & Perspectives
  63. Cannabinoids, cannabinoid receptors and tinnitus
    Paul F. Smith, Yiwen Zheng · 2015 · Hearing Research
  64. The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets
    Fabio Arturo Iannotti, Vincenzo Di Marzo · 2025 · Pharmacological Reviews
  65. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target
    David R. Janero, Ganesh A. Thakur · 2016 · Expert Opinion on Drug Discovery
  66. Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent
    Alyssa S. Aebersold, Maxwell B. Duff, Lucy J. Sloan, Zhao-Hui Song · 2021 · Cellular Physiology and Biochemistry
  67. Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol
    Christopher Kudrich, Yasmin L. Hurd, Edwin A. Salsitz, An‐Li Wang · 2021 · Cannabis and Cannabinoid Research
  68. Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor α2 subunit
    Dustin J. Hines, April Contreras, Betsua Garcia, Jeffrey S. Barker, Austin J. Boren, Christelle Moufawad El Achkar, Stephen J. Moss, Rochelle M. Hines · 2022 · Molecular Psychiatry
  69. Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003–2017
    A. Reece, G. Hulse · 2022 · Environmental epigenetics
  70. Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression
    Uri Bright, Irit Akirav · 2023 · International Journal of Molecular Sciences
  71. Toll-like receptor signalling as a cannabinoid target
    Melody Cui Sun, Almudena Otálora-Alcaraz, Jack A. Prenderville, Eric J. Downer · 2024 · Biochemical Pharmacology
  72. The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review
    Ai Kuzumi, Asako Yoshizaki‐Ogawa, Takemichi Fukasawa, Shinichi Sato, Ayumi Yoshizaki · 2024 · American Journal of Clinical Dermatology
  73. From Cannabinoids and Neurosteroids to Statins and the Ketogenic Diet: New Therapeutic Avenues in Rett Syndrome?
    Francisco M. Mouro, Catarina Miranda‐Lourenço, Ana Maria Sebastião, Maria José Diógenes · 2019 · Frontiers in Neuroscience
  74. 2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide Activity
    Leanne Lu, Gareth Haydn Williams, Patrick Doherty · 2019 · Cannabis and Cannabinoid Research
  75. Cannabinoids in the Treatment of Back Pain
    Teddy E. Kim, Robert Kyle Townsend, Charles L. Branch, Edgar Alfonso Romero-Sandoval, Wesley Hsu · 2020 · Neurosurgery
  76. Understanding the complex pharmacology of cannabidiol: Mounting evidence suggests a common binding site with cholesterol
    Lewis J. Martin, Samuel D. Banister, Michael T. Bowen · 2021 · Pharmacological Research
  77. Beyond the hype: a comprehensive exploration of CBD’s biological impacts and mechanisms of action
    Karli S. Swenson · 2025 · Journal of Cannabis Research
  78. Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function
    Iu Raïch, Jaume Lillo, Joan Biel Rebassa, Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Irene Reyes‐Resina, Rafael Franco, Mercè Pallàs, Gemma Navarro · 2025 · Alzheimer s Research & Therapy
  79. The Role of Organic Small Molecules in Pain Management
    Sebastian Adolfo Cuesta, Lorena Meneses · 2021 · Molecules
  80. Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies
    Dimitri Daldegan‐Bueno, Lucas Oliveira Maia, Michelle Glass, Didier Jutras‐Aswad, Benedikt Fischer · 2021 · European Neuropsychopharmacology
  81. Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents
    Flávia Pereira Dias Viegas, Vanessa Silva Gontijo, Matheus de Freitas Silva, Cindy Juliet Cristancho Ortiz, Graziella dos Reis Rosa Franco, Januário Tomás Ernesto, Caio Miranda Damásio, Isabela Marie Fernandes Silva, Thâmara Gaspar Campos, Cláudio Viegas · 2021 · Current Neuropharmacology
  82. Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules
    Ayat Zagzoog, Ashley Cabecinha, Hanan Abramovici, Robert B. Laprairie · 2022 · Frontiers in Pharmacology
  83. Pharmacological Characterization of the Endocannabinoid Sensor GRAB eCB2.0
    Simar J. Singh, Dennis Sarroza, Anthony English, Maya McGrory, Ao Dong, Larry S. Zweifel, Benjamin Bruce Land, Yulong Li, Michael R. Bruchas, Nephi Stella · 2023 · Cannabis and Cannabinoid Research
  84. An Overview of Cannabidiol
    Alexandra Sideris, Lisa Doan · 2023 · Anesthesia & Analgesia
  85. Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia
    Carlos Jiménez Naranjo, Ashleigh L. Osborne, Katrina Weston–Green · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  86. Cannabis Phytochemicals: A Review of Phytocannabinoid Chemistry and Bioactivity as Neuroprotective Agents
    Dylan T. Marsh, Scott Darryl Smid · 2020 · Australian Journal of Chemistry
  87. Understanding Cannabis-Based Therapeutics in Sports Medicine
    Gretchen Maurer, Neilson M. Mathews, Kevin T. Schleich, Tyler G. Slayman, Britt L. Marcussen · 2020 · Sports Health A Multidisciplinary Approach
  88. Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats
    Vinícia Garzella Metz, Jéssica Leandra Oliveira da Rosa, Domênika Rubert Rossato, Laura Hautrive Milanesi, Marilise Escobar Bürger, Camila Simonetti Pase · 2021 · European Neuropsychopharmacology
  89. Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice
    Juan Carlos Ledesma, Carmen Manzanedo, M.A. Aguilar · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  90. Effects of cannabinoids on the development of chick embryos in ovo
    Sofia B. Gustafsson, Stig O. P. Jacobsson · 2019 · Scientific Reports
  91. Anorexigenic effects induced by RVD-hemopressin(α) administration
    Claudio Ferrante, Lucia Recinella, Sheila Leone, Annalisa Chiavaroli, Chiara Di Nisio, Sara Martinotti, Adriano Mollica, Giorgia Macedonio, Azzurra Stefanucci, Szabolcs Dvorácskó et al. · 2017 · Pharmacological Reports
  92. A critical review of cannabis in medicine and dentistry: A look back and the path forward
    Ammaar H. Abidi, Sahar S. Alghamdi, Karen J. Derefinko · 2022 · Clinical and Experimental Dental Research
  93. Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
    Cecilia Zavala‐Tecuapetla, Hiram Luna‐Munguía, María Leonor López‐Meraz, Manola Cuéllar‐Herrera · 2022 · International Journal of Molecular Sciences
  94. Dietary Galacto‐Oligosaccharides and Resistant Starch Protect Against Altered CB1 and 5‐HT1A and 2A Receptor Densities in Rat Brain: Implications for Preventing Cognitive and Appetite Dysfunction During a High‐Fat Diet
    Yinghua Yu, Craig S Patch, Katrina Weston–Green, Yuan Zhou, Kuiyang Zheng, Xu‐Feng Huang · 2018 · Molecular Nutrition & Food Research
  95. The Therapeutic Effectiveness of Full Spectrum Hemp Oil Using a Chronic Neuropathic Pain Model
    Jacob Miguel Vigil, Marena A. Montera, Nathan S. Pentkowski, Jegason P. Diviant, Joaquin Orozco, Anthony L. Ortiz, Lawrence J. Rael, Karin N. Westlund · 2020 · Life
  96. THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways
    Hanna J. Szkudlarek, Mar Rodríguez-Ruiz, Roger Hudson, Marta De Felice, Tony Jung, Walter J. Rushlow, Steven R. Laviolette · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  97. Cannabinoids and COVID-19
    Myriam El Biali, Barbara Broers, Marie Jo Besson, Jules Demeules · 2020 · Medical Cannabis and Cannabinoids
  98. Cannabidiol and Other Cannabinoids in Demyelinating Diseases
    Carmen M. Navarrete, Adela García‐Martín, Alain P. Rolland, Jim DeMesa, Eduardo Muñóz · 2021 · International Journal of Molecular Sciences
  99. Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target
    Eulla Keimili Fernandes Ferreira Cavalheiro, Ana Beatriz Costa, Daniéle Hendler Salla, Mariella Reinol da Silva, Talita Farias Mendes, Larissa Espindola da Silva, Cristini da Rosa Turatti, Rafael Mariano de Bitencourt, Gislaine Tezza Rezin · 2021 · Cannabis and Cannabinoid Research
  100. Cannabidiol and the possibilities of its use in veterinary medicine of dogs and horses: A brief review
    Leoš Landa, Václav Trojan, Regina Demlová, Jan Juřica, Radovan Hřib · 2022 · Veterinární Medicína